Analysis of multi-site HPV infection and vaccination willingness among men who have sex with men in Tianjin, China
Authors:
Open Access
- 14 October 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1453024
Abstract
Background: Men who have sex with men (MSM) are vulnerable to HPV infection. This study aims to explore the HPV infection status at different sites among HIV-positive MSM, HIV-negative MSM, and men who have sex with women (MSW), and to investigate their willingness to receive HPV vaccination.Methods: From September 2023 to April 2024, three groups were recruited in Tianjin, China. Participants completed an electronic self-administered questionnaire, which included demographic information, knowledge related to sexually transmitted diseases, behavioral information, and willingness to receive the HPV vaccine. Samples were collected from the anal region, genitals, and oral cavity for HPV typing.Results: A total of 1,559 participants were recruited, including 300 HIV-positive MSM, 600 HIV-negative MSM, and 659 MSW. The HPV infection prevalence for any site were 62.0, 53.7 and 8.3%, respectively (p < 0.001). The infection prevalence for HPV genes covered by the 9-valent vaccine were 47.0, 36.8, and 3.5%, respectively (p < 0.001). Co-infection prevalence at anal and genital were 20.3, 14.2, 0.6%, respectively. Co-infection prevalence at anal and genital and oral were 1.3, 0.3%, 0, respectively. A total of 77.0% HIV-positive MSM and 75.3% HIV-negative MSM expressed willingness to receive the HPV vaccine, whereas 58.9% of MSW were unwilling (p < 0.001). Being HIV-positive (aOR, 3.119; 95% CI, 2.213–4.395), being over 46 years old (aOR, 1.994; 95% CI, 1.266–3.142), with an occupation classified as “white collar workers” (aOR, 1.620; 95% CI, 1.111–2.362) and “freelancing” (aOR, 2.025; 95% CI, 1.371–2.993) and a history of homosexual behavior in the past 6 months (aOR, 5.338; 95% CI, 3.802–7.495) were risk factors for HPV infection among men in Tianjin. Consistently using condoms in the past 6 months (aOR, 0.667; 95% CI, 0.513–0.867) were protective factors.Conclusion: The HPV infection prevalence among MSM in Tianjin is significantly higher than among MSW, with higher prevalence in the anal region compared to the genital and oral region. HPV infection is associated with HIV infection, older age, and homosexual behavior. Most MSM showed a positive willingness to receive the HPV vaccine, indicating the necessity to implement targeted HPV vaccination programs for MSM and to enhance necessary preventive knowledge and behavioral interventions.Keywords
This publication has 30 references indexed in Scilit:
- Associations of mothers’ decisional conflicts and satisfaction with governmental health promotion materials with their daughters’ HPV vaccination uptake in China: A cross-sectional surveyVaccine: X, 2024
- Case-finding for HPV vaccination eligibility within a dental office with concurrent development of a dialogue toolVaccine: X, 2024
- Barriers to the assessment and recommendation of HPV vaccination among healthcare providers in TexasVaccine: X, 2024
- Risk factors for human papillomavirus infection and disease: A targeted literature summaryJournal of Medical Virology, 2024
- Human papillomavirus in menRevista Internacional de Andrología, 2022
- Human papillomavirus prevalence among men who have sex with men in China: a systematic review and meta-analysisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2021
- Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with menJournal of Medical Virology, 2017
- Prevalence of Genital Human Papillomavirus Infection and Human Papillomavirus Vaccination Rates Among US Adult MenJAMA Oncology, 2017
- Influence of age and CD4+ T cell counts on the prevalence of genital human papillomavirus infection among HIV‐seropositive men who have sex with men in TaiwanJournal of Medical Virology, 2012
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999